Literature DB >> 11070030

Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage.

A J Dal Canto1, H W Virgin, S H Speck.   

Abstract

The role of autoimmunity in large-vessel vasculitis in humans remains unclear. We have previously shown that infection of gamma interferon receptor knockout (IFN-gamma R(-/-)) mice with gammaherpesvirus 68 (gamma HV68) results in severe inflammation of the large elastic arteries that is pathologically similar to the lesions observed in Takayasu's arteritis, the nongranulomatous variant of temporal arteritis, and Kawasaki's disease (K. E. Weck et al., Nat. Med. 3:1346-1353, 1997). Here we define the mechanism of damage to the elastic arteries. We show that there is a persistent productive infection of the media of the large elastic vessels. In addition, we demonstrate that persistent virus replication is necessary for chronic arteritis, since antiviral therapy of mice with established disease resulted in increased survival, clearance of viral antigen from the media of the affected vessel, and dramatic amelioration of arteritic lesions. These data argue that ongoing virus replication, rather than autoimmunity, is the cause of gamma HV68-induced elastic arteritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070030      PMCID: PMC113235          DOI: 10.1128/jvi.74.23.11304-11310.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

Review 2.  New developments in pathogenesis of systemic vasculitis.

Authors:  R Nowack; L F Flores-Suárez; F J van der Woude
Journal:  Curr Opin Rheumatol       Date:  1998-01       Impact factor: 5.006

Review 3.  Infection and coronary heart disease.

Authors:  R W Ellis
Journal:  J Med Microbiol       Date:  1997-07       Impact factor: 2.472

4.  Four tRNA-like sequences and a serpin homologue encoded by murine gammaherpesvirus 68 are dispensable for lytic replication in vitro and latency in vivo.

Authors:  J P Simas; R J Bowden; V Paige; S Efstathiou
Journal:  J Gen Virol       Date:  1998-01       Impact factor: 3.891

Review 5.  Modulation of antigen processing and presentation by persistent virus infections and in tumors.

Authors:  R Ehrlich
Journal:  Hum Immunol       Date:  1997-05       Impact factor: 2.850

6.  Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.

Authors:  M von Herrath; A Holz
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

7.  Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.

Authors:  B M Dutia; C J Clarke; D J Allen; A A Nash
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 8.  Infections and systemic vasculitis.

Authors:  B F Mandell; L H Calabrese
Journal:  Curr Opin Rheumatol       Date:  1998-01       Impact factor: 5.006

9.  In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.

Authors:  J Neyts; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease.

Authors:  K E Weck; A J Dal Canto; J D Gould; A K O'Guin; K A Roth; J E Saffitz; S H Speck; H W Virgin
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

View more
  33 in total

1.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

4.  Early establishment of gamma-herpesvirus latency: implications for immune control.

Authors:  Emilio Flaño; Qingmei Jia; John Moore; David L Woodland; Ren Sun; Marcia A Blackman
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

5.  A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge.

Authors:  Janice M Moser; Michael L Farrell; Laurie T Krug; Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication.

Authors:  Vera L Tarakanova; Van Leung-Pineda; Seungmin Hwang; Chiao-Wen Yang; Katie Matatall; Mickael Basson; Ren Sun; Helen Piwnica-Worms; Barry P Sleckman; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2007-06-14       Impact factor: 21.023

7.  Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection.

Authors:  Joshua J Obar; Shinichiro Fuse; Erica K Leung; Sarah C Bellfy; Edward J Usherwood
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.

Authors:  Erik S Barton; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Epstein-Barr virus associated peri-implantitis: a split-mouth study.

Authors:  Fernando Verdugo; Ana Castillo; Francisca Castillo; Agurne Uribarri
Journal:  Clin Oral Investig       Date:  2014-05-07       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.